The global market for products in wound closure — encompassing sealants, glues, hemostasis, anti-adhesion as well as traditional tapes, sutures, clips and mechanical closure — will grow at a compound annual rate of 8.5% through 2017 according to the February 2012 report #S190, from MedMarket Diligence.
"Worldwide Surgical Sealants, Glues, Wound Closure and Anti-Adhesion Markets, 2010-2017" details the current market and its outlook for the full range of products used to effect wound closure. See link.
Sutures, despite being the most commonly used method of physically securing wounds and having been the mainstay of surgeons for literally hundreds of years, remains a dominant product in wound closure, given its great familiarity in routine practice by surgeons. Its evolution to include bioresorbable types, to improve its performance in the overall management of surgical and traumatic wounds, has served to strengthen sutures' persistent value in clinical practice. Nonetheless, fibrin and other sealants, hemostatic agents, and high-strength adhesives have begun to challenge sutures' monopoly over wound closure and management by offering the benefits of less blood loss, better wound sealing, better cosmetic results and other benefits. Advanced wound closure products have also gained an adjunctive role — alongside sutures — in improving the performance of sutures by enabling better annealing of the wound edges, sealing against blood, fluid or air leaks and faster healing of the surgical and chronic wound.
MedMarket Diligence has completed its comprehensive 2012 assessment of this global market to reveal the size, outlook and opportunities for current and hopeful competitors in each technology and geographic area. This report details the complete range of sealants & glues technologies used in traumatic, surgical and other wound closure, including tapes, sutures/staples/mechanical closure, hemostats, fibrin sealants/glues and medical adhesives and anti-adhesion products.
The report details current clinical and technology developments, with data on products in development (detailing market status) and on the market; market size and forecast; competitor market shares; competitor profiles; and market opportunity. The report provides full year actual data for 2011 and forecast to 2017 of the markets for these technologies, with emphasis on the market impact of new technologies through the forecast period. The report provides specific forecasts and shares of the worldwide market by segment for Americas (detail for U.S., Rest of North America and Latin America), Europe (detail for United Kingdom, German, France, Italy, Spain, Rest of Europe), Asia/Pacific (detail for Japan, Korea, Rest of Asia/Pacific) and Rest of World.
The report provides background data on the surgical, disease and traumatic wound patient populations targeted by current technologies and those under development, and the current clinical practices in the management of these patients, including the dynamics among the various clinical specialties or subspecialties vying for patient population and facilitating or limiting the growth of technologies. The report establish the current worldwide market size for major technology segments as a baseline for and projecting growth in the market through 2017. The report assesses and projects the composition of the market as technologies gain or lose relative market performance over this period. The report profiles 122 active companies in this industry, providing data on their current products, current market position and products under development.